Naturally-Acquired Immunity in Malaria {#s1}
======================================

Only after years of continued exposure to *Plasmodium* parasites do individuals from malaria endemic regions develop clinical immunity (CI), that protects against clinical disease but not from parasitaemia ([@B1]). This protection is mediated through both cellular and humoral immune effector mechanisms. In particular, humoral immunity (HI) apparently plays a pivotal role against blood-stages, which are responsible for pathology and disease. Seminal findings demonstrate that IgG transfer from malaria-immune adults to children with acute malaria can indeed reduce symptoms and parasite load ([@B2]).

Effective HI induction requires B cells to be activated by antigen-presenting cells (APCs), predominantly dendritic cells (DCs). Sustained "help" from cognate CD4^+^ T cells is subsequently required for B cell proliferation, affinity maturation, and Ig class-switching. T follicular helper cells (T~FH~), which co-localize with B cells in the germinal centers (GCs), are crucial for both naïve B cell activation during primary infections and reactivation of memory B cells (MBC) in secondary infections. T~FH~ and other CD4^+^ helper T cells (T~H~) can drive naive B cells to differentiate into high-antibody-producing plasma cells (PC) or MBC, which rapidly reactivate and produce specific Abs during secondary infections.

While typically taking a number of years to develop fully, clinical malaria immunity is of relatively short duration and rapidly wanes in the absence of re-infection ([@B3], [@B4]). Antibody efficacy and specific MBC counts increase gradually with age and cumulative exposure, resulting in a strong T~H~1 (IFN-γ-producing) immune response ([@B5]--[@B9]). The origins of the relatively slow acquisition of clinical immunity, however, remain elusive.

Here we hypothesize that T cell responses generated by repeated blood-stage malaria infection may in fact delay the onset of potent humoral responses. We contextualize the role of T~H~ and T~FH~ polarization surrounding the B cell response in malaria, and suggest that excessive polarization toward the IFN-γ producing T~H~1 phenotype reduces the longevity of antibody responses.

B-cells and Plasma Cells Are Deregulated in Malaria {#s2}
===================================================

Potent humoral responses are characterized by the generation of specific and high-affinity long-lived PCs (LLPCs) and MBCs in the GCs. Yet both adults and children in malaria endemic areas show a delay in the development of MBC and short-lived antibodies targeting *P. falciparum* blood-stage antigens ([@B10]). Accordingly, antibodies generated during one acute malaria season are undetectable by the next ([@B10]). Similar delays in CI onset are found in malaria-naïve immigrants to Papua New Guinea ([@B11]).

Sustained parasitaemia may be a key factor affecting B cell differentiation. Recent studies have provided valuable insights into B cell subset dynamics and antibody kinetics in the context of *Plasmodium* infection. While it is clear that IgG^+^ MBCs are key effectors in long-term memory, high levels of non-IgG^+^ anti-*P. falciparum* MBCs may have a role in early protection ([@B12]). Frequent exposure to asexual parasites, as experienced in highly malaria-endemic regions, is associated with the development of MBCs with reduced memory function, known as atypical memory B-cells (AMBC). While the presence of AMBCs may contribute to the delayed and short-lived nature of HI to malaria ([@B13]), their presence may also be symptomatic of a more broadly deregulated humoral response.

Frequent parasite exposure seems to be a driving factor in AMBC development. AMBC frequency increases proportionate to transmission intensity, age, and cumulative malaria exposure ([@B13]--[@B19]), and AMBC proportions increase after each acute malaria episode ([@B20]). Conversely, the percentage of AMBCs declines in the absence of parasite exposure, inducing stable populations of malaria-specific classical MBCs ([@B17], [@B19], [@B21], [@B22]). This may be the result of direct B cell interactions with *Plasmodium* parasites, or indirectly generated by the pro-inflammatory environment ([@B23], [@B24]), or by a combination of the two, i.e., AMBCs as a product of persistent antigen engagement by B cells within a highly inflammatory environment of chronic malaria exposure, driven by T~H~1 cells ([@B25]).

Hence, inappropriate IFN-γ production may be a reflection of inadequate T cell help caused by frequent exposure to blood-stage *P. falciparum*.

Blood-Stage Infection Induces Changes in T Cell Phenotypes and Populations {#s3}
==========================================================================

Malaria parasites typically induce human T cells with high surface expression of PD-1 and LAG3 and high production of both IFN-γ and IL-10 ([@B26]--[@B28]). Hence, CD4^+^ T cells in the malarial environment frequently display a phenotype associated with immunosuppression. Furthermore, the malarial environment polarizes CD4^+^ T cells toward the IFN-γ-producing T~H~1-like phenotype, consequently reducing B-cell responses by suppressing antibody-inducing T~H~2 and T~FH~ lineages. While this may be beneficial for containing parasite-mediated pathology, it may contribute to immunopathology and limit reactivation of long-lived MBC. Modeling analyses by Lonnberg et al indicate that monocytes in particular have a role in regulating the T cell response, producing cytokines which skew naïve cells away from the T~FH~ lineage and toward a T~H~1 phenotype ([@B26]).

The Impact of T~FH~ Cells on Humoral Immunity {#s4}
=============================================

The T~FH~ subset is particularly crucial for B cell development in the GC and the subsequent generation of a functional memory B cell compartment. T~FH~ responses are widely hypothesized to be disrupted in malaria, as reflected by the relatively high frequency of autoreactive AMBCs and classical MBCs ([@B29]).

Due to the challenges of obtaining secondary lymphoid tissue, human research on T~FH~ cells has primarily concentrated on circulatory CD4^+^CXCR5^+^ T~FH~ ([@B30]). These circulatory T~FH~ cells share functional characteristics with GC T~FH~ cells including IL-21 production and the ability to induce B cell differentiation *in vitro* ([@B31]). They also have properties of a central memory-like T~FH~ population ([@B26], [@B31]--[@B34]). In contrast to GC-resident T~FH~, however, circulatory T~FH~ cells lack BCL6 expression, which is required for survival and induction of secondary antibody responses ([@B31], [@B35]--[@B38]). BCL6 re-expression can be induced by re-challenge with cognate MBC ([@B39]), indicating that sustained antigen presence is required for T~FH~ function.

In the last decade, circulatory T~FH~ subsets equivalent to T~H~1, T~H~2, T~H~17, and T~REG~ have been characterized in mice and humans ([@B40], [@B41]). T~H~1-like T~FH~ cells (T~FH~1) show reduced potential to provide adequate help during antibody maturation *ex vivo* compared to T~H~2-like T~FH~ cells (T~FH~2) ([@B33], [@B35], [@B42]). The concept that T~FH~ subset imbalance may affect development of antimalarial immunity has gained more traction due to T~FH~ subsets\' potential roles in other chronic diseases, such as HIV ([@B43]). In parallel, polarization toward T~H~1-like responses has been well-documented in malaria and causes fundamental changes in multiple cell subtypes, such as induction of Th1-like regulatory cells (T~REG~1) ([@B6], [@B28], [@B44]).

Thus, dysfunctional GC processes and inappropriate T~FH~ reactions are a likely consequence of malaria infection. Indeed, polarization of T~FH~ is observed in Malian children, with more activated T~FH~1, more T~H~1-like cytokine responses, and less prominent T~H~2 polarization ([@B26], [@B34], [@B45]--[@B47]). This T~H~1-like cytokine response may lead to decreased GC reactions and therefore reduced generation and reactivation of T cell-dependent antibody responses ([Figure 1](#F1){ref-type="fig"}).

![T~H~1-like T cell responses in malaria. Follicular T helper cells are required for B cell activation and the generation of humoral immunity, but malaria profoundly affects T cell polarization and leads to short-lived antibody responses. The presence of asexual parasitaemia promotes activation of T~H~1 and NK cells, which produce high levels of IFN-γ. This microenvironment promotes cellular upregulation of exhaustion markers like LAG3 and PD-1 and T~FH~ differentiation into T~FH~1 cells, which are less effective at activating B cells. Quality of the T cell help in malaria-driven inflammation is therefore reduced, leading to B cell apoptosis or differentiation into short-lived plasma cells and atypical memory B cells, which are poor contributors to the long-term maintenance of humoral immunity.](fimmu-10-01096-g0001){#F1}

Murine data suggest that circulatory T~FH~ may represent pre-T~FH~ generated from partly committed T~FH~ lineage cells rather than mature memory GC-derived T~FH~ cells ([@B45]). In murine malaria models, frequency of pre-T~FH~ expressing the T~H~1-associated transcription factor Tbet increases after a single *P. bergei* ANKA infection ([@B46]). It will be important to clarify whether malaria-induced circulating T~FH~1 are simply pre-T~FH~ generated in the periphery after a single exposure without entering the GC, and if circulating T~FH~2 therefore represent the mature T~FH~ memory pool. This may explain the differential functionality of these two T~FH~ subtypes in malaria. A proper understanding of the relationship between circulating- and GC T~FH~ will be essential to delineate their particular role in the development of HI.

How Is the T~H~1-like Signature and T~FH~1-like Polarization Realized? {#s5}
======================================================================

Studies with transgenic murine *P. yoelii* parasites suggest a positive feedback loop induced by Type I interferon and IL-2; T~H~1 cytokines secreted during *Plasmodium* infection increase CD4^+^ T cell responsiveness by up-regulating Tbet and BLIMP-1 ([@B44], [@B47]). Consequently, CD4^+^ T cells gain an increased predisposition to become T~H~1 cells.

Deregulation of humoral malaria immunity may be the result of an increased T~FH~1:T~FH~2 ratio in combination with the efficacy of the individual responses. Sustained polarization toward a T~FH~1 response after a single infection may affect an individual\'s ability to respond to subsequent malaria episodes. Frequencies of CXCR3^+^CCR6^−^ T~FH~1s increase transiently but significantly during acute malaria, while CXCR3^−^CCR6^−^ T~FH~2 frequencies decrease long-term in response to multiple malaria parasite exposures ([@B48]). In addition, T cell co-receptors may play a role in regulating T~FH~ activation, as shown in *P. yoelli*-infected mice, where activation of OX40 leads to up-regulation of IFN-γ ([@B49]), resulting in activation of the inhibitory PD-1 pathway. Consequently, T~FH~ help will shut down, resulting in dysfunctional B cell responses including the generation of AMBCs ([@B25]) and decreased parasite clearance due to lower specific IgM and IgG titres ([@B49], [@B50]). Therefore, CXCR3^+^ over-activation may be an important albeit not exclusive factor that limits T cell-dependent antibody responses to *Plasmodium*.

Co-infection with other pathogens can also impact humoral immunity to malaria. Multiple murine studies demonstrated that co-infection with murine Epstein-Barr virus analog MHV68 during *P. yoelii* XNL infection led to very high mortality from symptoms of malaria ([@B51], [@B52]). The latter study indicated that mortality was due to loss of humoral immunity by the MHV68 virus via induction of host IL-10 ([@B52]). Host factors involved in parasite sensing can also have a role: humanized mice engineered to express a single MHCII haplotype, HLA-DR4 (0401), had higher rates of parasitaemia and morbidity to *P. yoelii* 17XNL infection than mice engineered to express alternate haplotypes. The loss of parasite control was due to downregulation of humoral immunity by overproliferating T~REG~s ([@B53]).

Other Checkpoint Factors Influencing T Cell Differentiation in Malaria {#s6}
======================================================================

Regulatory T cell subtypes are likely key modulators of HI. The recently characterized regulatory follicular helper T cell (T~FR~) subset is especially relevant for HI regulation. Contrary to T~R~1, which arise from T~H~1, T~FR~ are a FOXP3^+^ subclass derived directly from T~REG~ which express both BCL-6 and BLIMP-1 ([@B54]). Crucially, T~FR~ can directly suppress both T~FH~ and B cells in GC reactions and therefore directly affect GC formation ([@B55]--[@B59]).

T~FR~ have not yet been studied in the context of malaria, even though their importance is indicated by their key role in controlling antibody production in HIV ([@B60]). T~FR~ cell functionality is assumed to be determined by their ratio with T~FH~. As the proportion of T~FR~ increases with age, similarly to T~REG~s ([@B57]), we hypothesize that T~FR~ have the potential to play a role in the delayed onset of NAI. Murine studies show that the T~FR~ fraction increases with age while the T~FH~ proportion remains constant ([@B60]). T~FR~ may therefore progressively regulate the T~H~1 driven over-activation of DCs, T cells and B-cells.

Conversely, a higher T~FR~:T~FH~ ratio may inhibit T~FH~ activation and proliferation, as suggested by T~FR~-induced downregulation of the proliferation marker Ki67 in T~FH~ cells *in vitro*, dampening T~FH~1 activation ([@B61], [@B62]). However, T~FR~ also downregulate the T~H~2-associated cytokines IL-21 and IL-4 in *in vitro* murine studies, potentially leading to marked defects in GC formation, and B cell affinity maturation ([@B61], [@B63]--[@B65]). Changes in the T~FR~:T~FH~ ratio may therefore redirect GC B cells toward becoming extra-follicular MBCs and short-lived PCs, therefore further decreasing generation of long-lived high-affinity antibodies ([@B58], [@B62]).

Summary, Conclusions, and Outlook {#s7}
=================================

Malaria infection induces T~H~1 polarization characterized by the production of IFN-γ. Overproduction of IFN-γ may be central to poor acquisition of HI by polarizing T~FH~ toward T~FH~1 and causing a positive feedback loop of T~H~1 polarization. It will be crucial to understand the specific parasite components responsible for T~H~1 polarization so that we can better target parasite antigens which catalyze T~H~1 polarization.

Malaria-naïve adults and children from low-transmission regions tend to generate strong pro-inflammatory responses: T~H~1 cytokines IFN-γ and TNFα, and other pro-inflammatory cytokines such as IL-1β and IL-6, are produced, which may favor generation of T~H~1-like responses. However, children with sustained parasitaemia develop a cytokine signature consisting of IFN-γ, Type I IFN, and regulatory cytokines IL-10 and TGF-β ([@B9], [@B66], [@B67]). It is unclear whether this is related to parasite density, incidence of infections, or both. Parasite burden and transmission intensity could affect T~FH~ polarization through systemic cytokine-mediated effects.

Dendritic cells and NK cells may be responsible for maintaining T~H~1 polarization. Malaria could affect early T cell polarization by disrupting dendritic cell function ([@B68], [@B69]), and DCs co-incubated with blood-stage parasites *in vitro* are shown to polarize naïve T cells toward a T~H~1-like phenotype that produces IFN-γ and TNFα ([@B70], [@B71]). Furthermore, DCs are required for NK cell activation to blood-stage parasites ([@B72]). NK cells are major producers of IFN-γ, and rapid reactivation of NK cells in response to blood-stage infection could lead to the formation of a T~H~1 cytokine signature, thereby inhibiting development of positive HI-forming responses. The presence of memory-like responses (trained immunity) from NK cells upon re-encountering pRBCs *in vitro* ([@B73]) suggests that NK cell activation in response to malaria may occur rapidly after the first infection, increasing early tendencies toward Th1-like responses. Moreover, NK cell cross-talk with dendritic cells is important for CD4 T cell priming in murine malaria models ([@B74], [@B75]), suggesting that NK cells may bias T~H~1 polarization through multiple pathways.

However, it is unclear whether the blood-derived T~FH~ differ functionally from their GC counterparts. Better models of T~FH~ will be required to study these differences and assess the functional relationship between T~FH~ subsets and the generation of humoral immunity more thoroughly: what phenotypes are generated by B-cells co-stimulated by T~FH~1, the quality of the antibody response, and whether their ability to differentiate into LLPCs or classical MBCs is impacted by malaria-generated T~FH~1s. A culture system to induce T~FH~ or novel systems such as humanized mice which could generate larger quantities of T~FH~ and even allow for isolation of tissue-resident T~FH~ would permit further, in-depth study of these cells. This would also permit mechanistic studies into how T~FH~1 polarization occurs.

In summary, malaria infection, especially repeated infection with high parasitaemia, may generate "inappropriate" T~H~1-like T cell responses that fail to provide the adequate environment for long-lasting HI. This may be due to (i) compromised T~FH~ help, reducing the generation of functional GC and development of typical memory B-cells, leading to a loss of HI longevity; (ii) increased proliferation of regulatory subsets such as T~FR~ which may further inhibit HI by decreasing T~FH~ activation and proliferation; (iii) a strong T~H~1-like immune signature characterized by high production of IFN-γ, illustrated by the increased fraction of T~H~1 and other T~H~1-like cells, including the T~FH~1 subset. To break the cycle, we need improved methods to study T~FH~ and understand the underlying mechanisms of T~H~1 polarization in malaria.
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